BREAKING NEWS: GMC overhaul set to clamp down on racism and sexual abuse

General Medical Council (GMC) reforms designed to clamp down on racism and sexual abuse have been put forward by the Government.

(c) Hush Naidoo Jade Photography

(c) Hush Naidoo Jade Photography

The consultation on the GMC Order follows a rapid review into antisemitism and other forms ofracism in the health service by Lord John Mann in November.

Health and social care secretary Wes Streeting said:The NHS is a universal health service, which means that everyone, regardless of race, religion, orbelief, should feel safe seeking its care. It is unacceptable that this is not the current reality for many patients and staff, and I will not allow it to continue.'

The GMC Order will consult on deliveringthree key changes:

The GMC will retain its existing right to appeal decisions made by the Medical Practitioners Tribunal Service (MPTS) to the Courts, ensuring there remains a robust check on fitness to practise outcomes

The Professional Standards Authority (PSA) — the body that oversees all healthcare regulators — will receive new powers to challenge interim decisions made by the MPTS, and the GMC will receive equivalent powers

Regulators will be required to share information with the PSA when requested, strengthening the PSA's ability to scrutinise regulatory decisions and intervene where necessary.

The consultation also proposes removing the current rule which prevents regulators from being able to consider fitness to practise concerns involving allegations of historic sexual abuse after five years have passed.   

Reaction

Alan Clamp, PSA chief executive said: ‘As the oversight body, we welcome the new power proposed for us to be able to require the GMC to provide information to us. This will be important in making sure we can access all of the information we need to assess the regulator against our standards when the new legislation is in place.'

Tom Reynolds, director of policy & communications at The MDU, said ‘proposals that the GMC should retain its right of appeal over MPTS decisions are profoundly concerning'.

Reynolds added: ‘These specific proposals should be called out for what they are: a betrayal. Since 2018, doctors have been repeatedly told – by successive governments – that as part of a reformed GMC legislative framework, the regulator would lose its right of appeal over tribunal decisions. Today, that promise lies in tatters.

 Members of the medical profession can be assured that the MDU is firmly opposed to this U-turn. We have campaigned for years for the GMC to lose this right of appeal and will continue to fight for this.'

Dr Pallavi Bradshaw, medical director at Medical Protection Society (MPS), said: ‘We are very concerned that the consultation on GMC reform proposes to maintain and in fact enhance the GMC's power to appeal medical tribunal decisions – despite the Government committing to removing it. Challenging tribunal decisions is and has long been the role of the Professional Standards Authority. The GMC is the only UK health regulator with a statutory right to appeal its own tribunal's decisions, which duplicates the PSA's powers. The proposed changes mean that a doctor would be subject to potential appeals from both bodies following either a substantive or interim sanction which is likely to lead to more delay, uncertainty and cost. This anomaly contributes to the increasing distrust between doctors and the regulator, and this is a disappointing development for the profession.'


Pharma company recalls antidepressant medication

Pharma company recalls antidepressant medication

By Lee Peart 29 April 2026

Pharma company Amarox Limited is recalling one batch of Sertraline 100mg film-coated tablets as a precautionary measure due to a manufacturing error that led...

EXCLUSIVE: 'Profound concern' over GMC 'policy reversal'

By Lee Peart 22 April 2026

Doctors have expressed ‘profound concern’ over Government plans to allow the GMC to retain its right of appeal over determinations of the Medical Practitione...

Blood pressure medication recall announced by MHRA

By Lee Peart 21 April 2026

Pharmacy and healthcare professionals have been advised to stop supplying a batch of blood pressures medication due to a manufacturing error.


Popular articles by Lee Peart